Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Genome Medicine|May 15, 2009
Musings on genome medicine: cancer genetics and the promise of effective treatmentDavid G Nathan, Stuart H OrkinMolecular Medicine (Cambridge, Mass.)|December 31, 2014
Advances in sickle cell therapies in the hydroxyurea eraJoshua J Field, David G NathanBlood|May 1, 2007
The ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum stabilizes spectrin tetramers and suppresses further invasionXinhong Pei, Xinhua Guo, Ross Coppel, et al.Biochemistry|August 3, 2005
Identification and functional characterization of protein 4.1R and actin-binding sites in erythrocyte beta spectrin: regulation of the interactions by phosphatidylinositol-4,5-bisphosphateXiuli An, Gargi Debnath, Xinhua Guo, et al.Seminars in Hematology|March 26, 2011
Diamond Blackfan anemia treatment: past, present, and futureAnupama Narla, Adrianna Vlachos, David G NathanBiochemistry|November 8, 2006
Thermal stabilities of brain spectrin and the constituent repeats of subunitsXiuli An, Xihui Zhang, Marcela Salomao, et al.Hematology/Oncology Clinics of North America|March 5, 2014
The role of adenosine signaling in sickle cell therapeuticsJoshua J Field, David G Nathan, Joel LindenClinical Immunology (Orlando, Fla.)|March 25, 2011
Targeting iNKT cells for the treatment of sickle cell diseaseJoshua J Field, David G Nathan, Joel LindenBiophysical Journal|August 5, 2021
αI-spectrin represents evolutionary optimization of spectrin for red blood cell deformabilityJohn Hale, Xiuli An, Xinhua Guo, et al.Plos One|October 15, 2013
NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptorsGene Lin, Joshua J Field, Jennifer C Yu, et al.Pageof 6